The OncoDaily Multiple Myeloma Congress 2026 is scheduled for April 23, 2026, as a virtual global congress streaming live on YouTube and X. This event addresses a global burden of approximately 188,000 new annual diagnoses and 120,000 deaths, representing 0.9% of all newly diagnosed cancers and 1.2% of cancer-related deaths worldwide. In the United States alone, 36,000 new cases are projected for 2026, highlighting the continued impact of this plasma cell malignancy.

The scientific program focuses on risk-adapted decision-making for newly diagnosed disease alongside evidence-based strategies for relapsed and refractory myeloma. Technical sessions examine the selection of systemic therapies, the sequencing of novel agents, and multidisciplinary coordination to optimize clinical outcomes and individualized patient care.

Registration is now open.